These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9535308)

  • 1. High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.
    Bassan H; Muhlbaur B; Tomer A; Spirer Z
    Pediatr Neurol; 1998 Feb; 18(2):181-3. PubMed ID: 9535308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis.
    Tagher RJ; Baumann R; Desai N
    J Pediatr; 1999 Feb; 134(2):233-5. PubMed ID: 9931536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
    Deguchi K; Matsuzono K; Nakano Y; Kono S; Sato K; Deguchi S; Tanabe K; Hishikawa N; Ota Y; Yamashita T; Ohta K; Motomura M; Abe K
    Intern Med; 2018 May; 57(10):1455-1458. PubMed ID: 29321424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis.
    Yasuda M; Uzawa A; Ozawa Y; Kojima Y; Onishi Y; Akamine H; Kuwabara S
    Scand J Immunol; 2022 Feb; 95(2):e13122. PubMed ID: 34796975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin in neonatal myasthenia gravis.
    Bassan H; Spirer Z
    J Pediatr; 1999 Dec; 135(6):790. PubMed ID: 10586190
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence.
    Gilhus NE; Hong Y
    Eur J Neurol; 2018 Dec; 25(12):1402-1409. PubMed ID: 30133097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous gamma-globulin in myasthenia gravis: interaction with anti-acetylcholine receptor autoantibodies.
    Liblau R; Gajdos P; Bustarret FA; el Habib R; Bach JF; Morel E
    J Clin Immunol; 1991 May; 11(3):128-31. PubMed ID: 1716263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis.
    Lee JY; Min JH; Han SH; Han J
    Neuromuscul Disord; 2017 Jul; 27(7):655-657. PubMed ID: 28495046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis crisis.
    Bershad EM; Feen ES; Suarez JI
    South Med J; 2008 Jan; 101(1):63-9. PubMed ID: 18176295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice.
    Vassilev T; Yamamoto M; Aissaoui A; Bonnin E; Berrih-Aknin S; Kazatchkine MD; Kaveri SV
    Eur J Immunol; 1999 Aug; 29(8):2436-42. PubMed ID: 10458757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange transfusion in neonatal myasthenia gravis.
    Donat JF; Donat JR; Lennon VA
    Neurology; 1981 Jul; 31(7):911-2. PubMed ID: 7195520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin.
    Cosi V; Lombardi M; Piccolo G; Erbetta A
    Acta Neurol Scand; 1991 Aug; 84(2):81-4. PubMed ID: 1950455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked hypotonia in an infant of a mother with Devic disease.
    Zifman E; Litmanovitz I; Segal G; Regev R; Watemberg N
    J Child Neurol; 2010 Jun; 25(6):746-7. PubMed ID: 20028941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2003; (2):CD002277. PubMed ID: 12804431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002277. PubMed ID: 16625559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.